Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Emory University |
---|---|
Information provided by: | Emory University |
ClinicalTrials.gov Identifier: | NCT00209144 |
The purpose of this study is to determine if intense control of high glucose levels in patients treated with angioplasty for heart attack has anti-inflammatory and anti-thrombotic effects.
Condition | Intervention | Phase |
---|---|---|
Acute Myocardial Infarction |
Drug: Intense glycemic control using intravenous insulin infusion |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Effects of Intense Glycemic Control on Markers of Inflammation and Thrombosis in Patients Treated With Percutaneous Coronary Intervention for Acute Myocardial Infarction. |
Estimated Enrollment: | 58 |
Study Start Date: | October 2004 |
Estimated Study Completion Date: | October 2006 |
Ages Eligible for Study: | 18 Years to 89 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria: Patients to be treated with percutaneous coronary intervention for myocardial infarction.
Exclusion Criteria: MI > 6 hrs duration Thrombolytic therapy (within last 2 days) Recent inflammatory/infectious illness (last 2 weeks) Pregnancy Renal insufficiency (Cr > 2.0) Type I Diabetes Mellitus Initial BG >110 but <140 Enrollment in another research study
Contact: Spencer J Palmer, MD | 404-686-1000 | spalm03@emory.edu |
United States, Georgia | |
Emory Crawford Long Hospital | Recruiting |
Atlanta, Georgia, United States, 30329 | |
Contact: Spencer J Palmer, MD 404-686-1000 spalm03@emory.edu | |
Contact: Douglas C Morris, MD 404-778-2253 douglas_morris@emoryhealthcare.org | |
Principal Investigator: Douglas C Morris, MD | |
Emory University Hospital | Recruiting |
Atlanta, Georgia, United States, 30322 | |
Contact: Spencer J Palmer, MD 404-686-1000 spalm03@emory.edu | |
Contact: Douglas C Morris, MD 404-778-2253 douglas_morris@emoryhealthcare.org | |
Principal Investigator: Douglas C Morris, MD |
Principal Investigator: | Douglas C Morris, MD | Emory Heart Center |
Study ID Numbers: | 867-2004, 6-56553 |
Study First Received: | September 14, 2005 |
Last Updated: | September 14, 2005 |
ClinicalTrials.gov Identifier: | NCT00209144 |
Health Authority: | United States: Institutional Review Board |
Inflammation Thrombosis Hyperglycemia Myocardial Infarction Angioplasty |
Necrosis Heart Diseases Hyperglycemia Myocardial Ischemia Vascular Diseases Ischemia |
Infarction Myocardial Infarction Insulin Thrombosis Inflammation |
Pathologic Processes Cardiovascular Diseases |